Evaluation of Serial Lung Ultrasound Data After Surfactant Treatments Applied With Different Methods in Preterm Babies
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-5
SponsorKonya City Hospital
About this trial
This study aims to investigate the relationship between the method of surfactant administration and improvements in serial lung ultrasound findings in preterm infants requiring surfactant therapy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Infants of families who agree to participate in the study
Preterm infants born before 32 weeks of gestation requiring surfactant therapy due to an RDS diagnosis.
Disqualifiers
Infants whose families did not provide consent
Infants with a syndromic appearance or congenital heart disease
Preterm infants born after 32 weeks of gestation
Trial design
Design model
Parallel
Treatments tested in this trial
Evaluation of serial lung ultrasound data after ENSURE surfactant treatments
Diagnostic testIntubating the infant, administering intratracheal surfactant, and then extubating them back to nasal respiratory support (ENSURE method)
Evaluation of serial lung ultrasound data after LISA surfactant treatments
Diagnostic testDelivering surfactant via a thin catheter (5F) directly into the trachea while the infant remains on existing nasal respiratory support, without disconnecting them from it (LISA method)
Treatment groups
68 Participants
are divided into 2 treatment groupsGroup A: Ensure groupExperimental treatment 1 intervention
Group B: Lisa groupExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Evaluation of serial lung ultrasound data after surfactant treatments
This study aims to investigate the relationship between the method of surfactant administration and improvements in serial lung ultrasound findings in preterm infants requiring surfactant therapy.
Time frame
6 hours after completion of surfactant administrationSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov